Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.
Clinical trial NCT02031276 · COMPLETED
Trial details
- NCT number
- NCT02031276
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-12-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.